Literature DB >> 15965469

Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models.

Simone Difilippantonio1, Arkady Celeste, Oscar Fernandez-Capetillo, Hua-Tang Chen, Bernardo Reina San Martin, Francois Van Laethem, Yong-Ping Yang, Galina V Petukhova, Michael Eckhaus, Lionel Feigenbaum, Katia Manova, Michael Kruhlak, R Daniel Camerini-Otero, Shyam Sharan, Michel Nussenzweig, André Nussenzweig.   

Abstract

Nijmegen breakage syndrome (NBS) is a chromosomal fragility disorder that shares clinical and cellular features with ataxia telangiectasia. Here we demonstrate that Nbs1-null B cells are defective in the activation of ataxia-telangiectasia-mutated (Atm) in response to ionizing radiation, whereas ataxia-telangiectasia- and Rad3-related (Atr)-dependent signalling and Atm activation in response to ultraviolet light, inhibitors of DNA replication, or hypotonic stress are intact. Expression of the main human NBS allele rescues the lethality of Nbs1-/- mice, but leads to immunodeficiency, cancer predisposition, a defect in meiotic progression in females and cell-cycle checkpoint defects that are associated with a partial reduction in Atm activity. The Mre11 interaction domain of Nbs1 is essential for viability, whereas the Forkhead-associated (FHA) domain is required for T-cell and oocyte development and efficient DNA damage signalling. Reconstitution of Nbs1 knockout mice with various mutant isoforms demonstrates the biological impact of impaired Nbs1 function at the cellular and organismal level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15965469     DOI: 10.1038/ncb1270

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  101 in total

1.  High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany.

Authors:  M H Maurer; K Hoffmann; K Sperling; R Varon
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  The radioprotective agent WR1065 protects cells from radiation damage by regulating the activity of the Tip60 acetyltransferase.

Authors:  Ye Xu; Kalindi Parmar; Fengxia Du; Brendan D Price; Yingli Sun
Journal:  Int J Biochem Mol Biol       Date:  2011-10-20

3.  Dynamics of the PI3K-like protein kinase members ATM and DNA-PKcs at DNA double strand breaks.

Authors:  Anthony J Davis; Sairei So; David J Chen
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

4.  Recruitment of DNA damage checkpoint proteins to damage in transcribed and nontranscribed sequences.

Authors:  Guochun Jiang; Aziz Sancar
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

5.  Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2.

Authors:  Xiaozhen Liang; Mary T Pickering; Nam-Hyuk Cho; Heesoon Chang; Michael R Volkert; Timothy F Kowalik; Jae U Jung
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.

Authors:  Erin R P Shull; Youngsoo Lee; Hironobu Nakane; Travis H Stracker; Jingfeng Zhao; Helen R Russell; John H J Petrini; Peter J McKinnon
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

Review 7.  DNA strand breaks, neurodegeneration and aging in the brain.

Authors:  Sachin Katyal; Peter J McKinnon
Journal:  Mech Ageing Dev       Date:  2008-03-25       Impact factor: 5.432

Review 8.  Mouse models of DNA double-strand break repair and neurological disease.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  DNA Repair (Amst)       Date:  2008-05-23

9.  A role for the MRN complex in ATR activation via TOPBP1 recruitment.

Authors:  Anja M Duursma; Robert Driscoll; Josh E Elias; Karlene A Cimprich
Journal:  Mol Cell       Date:  2013-04-11       Impact factor: 17.970

10.  Differential requirements of the C terminus of Nbs1 in suppressing adenovirus DNA replication and promoting concatemer formation.

Authors:  Seema S Lakdawala; Rachel A Schwartz; Kevin Ferenchak; Christian T Carson; Brian P McSharry; Gavin W Wilkinson; Matthew D Weitzman
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.